101![August 28, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of TENELIA® 20mg Tablets August 28, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of TENELIA® 20mg Tablets](https://www.pdfsearch.io/img/22fa5a476e432fb146805c17aa1274e6.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2012-08-27 03:43:16
|
---|
102![June 29, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval Received for TENELIA® 20mg Tablets June 29, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval Received for TENELIA® 20mg Tablets](https://www.pdfsearch.io/img/6fc3f22c0fbd744d79f47bb2861486b3.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2012-09-04 21:13:37
|
---|
103![February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy](https://www.pdfsearch.io/img/875f771d4ce89b0834046137d3c4cdd6.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2013-12-11 23:08:01
|
---|
104![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) Tablets Initia HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) Tablets Initia](https://www.pdfsearch.io/img/24fcc4cf610a140be1c8a6f11562641d.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-10-22 15:47:59
|
---|
105![97627XX HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. 97627XX HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA.](https://www.pdfsearch.io/img/c8f38ed9e0825dcf8f5449b3796710f8.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:10:45
|
---|
106![Merck Pipeline July 31, 2014
Merck Pipeline as of July 31, 20141 Phase 2 Merck Pipeline July 31, 2014
Merck Pipeline as of July 31, 20141 Phase 2](https://www.pdfsearch.io/img/ddde4b802cd7e0e728c1f3979c3b0e21.jpg) | Add to Reading ListSource URL: www.merck.comLanguage: English - Date: 2014-08-08 16:37:50
|
---|
107![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. Tradjenta® (linagliptin) tablets HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. Tradjenta® (linagliptin) tablets](https://www.pdfsearch.io/img/facec5cbbcb637a0c8daf0c96eeff135.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-05-27 14:10:03
|
---|
108![](https://www.pdfsearch.io/img/19d538658a7422584ce2c8b9c85a9744.jpg) | Add to Reading ListSource URL: media.wiley.comLanguage: English - Date: 2013-08-27 13:18:00
|
---|
109![Fact Sheet DPP-4 Inhibitors: Incretin-Based Medicine Type 2 Diabetes Fact Sheet DPP-4 Inhibitors: Incretin-Based Medicine Type 2 Diabetes](https://www.pdfsearch.io/img/350526ba7a91105e433406f44ba1e9c0.jpg) | Add to Reading ListSource URL: www.hormone.orgLanguage: English - Date: 2013-05-20 12:16:35
|
---|
110![INSTITUT NATIONAL D’ASSURANCE MALADIE-INVALIDITE SERVICE DES SOINS DE SANTE Comité d’ évaluation des pratiques médicales en matière de médicaments INSTITUT NATIONAL D’ASSURANCE MALADIE-INVALIDITE SERVICE DES SOINS DE SANTE Comité d’ évaluation des pratiques médicales en matière de médicaments](https://www.pdfsearch.io/img/560f86060255e297cec238aa75296273.jpg) | Add to Reading ListSource URL: www.riziv.fgov.beLanguage: English - Date: 2012-12-05 08:42:10
|
---|